Valuation: Edwards Lifesciences Corporation

Market Cap 50.87B 44.36B 41.89B 38.04B 71.27B 4,882B 71.56B 502B 194B 2,482B 191B 187B 7,986B P/E 2026 *
34.9x
P/E 2027 * 26.7x
Enterprise Value 47.24B 41.2B 38.9B 35.32B 66.18B 4,533B 66.46B 466B 180B 2,305B 177B 174B 7,416B EV / Sales 2026 *
6.99x
EV / Sales 2027 * 6.15x
Free-Float
86.96%
Yield 2026 *
-
Yield 2027 * -
1 day+0.01%
1 week+4.61%
Current month-2.74%
1 month-1.75%
3 months+1.03%
6 months+6.98%
Current year+3.53%
1 week 84.47
Extreme 84.47
89.7
1 month 83.81
Extreme 83.81
92.95
Current year 74.66
Extreme 74.66
96.29
1 year 72.3
Extreme 72.3
96.29
3 years 58.93
Extreme 58.93
96.29
5 years 58.93
Extreme 58.93
131.73
10 years 27.04
Extreme 27.04
131.73
Manager TitleAgeSince
Chief Executive Officer 58 2023-05-10
Director of Finance/CFO 43 2026-05-28
Chief Tech/Sci/R&D Officer 51 2025-08-31
Director TitleAgeSince
Chairman 69 2024-05-06
Director/Board Member 62 2015-02-09
Director/Board Member 58 2023-05-10
Date Insider Type Main position Quantity % Market Cap. Importance
9/14/26 Tax

Executive/Senior Manager

-568 0.0001%
9/13/26 Tax

Controller/Auditor

-253 0.0000%
9/11/26 Tax

Executive/Senior Manager

-398 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+0.01%+4.61%+18.61%+22.67% 50.87B
-1.04%+6.83%+35.84%+29.03% 241B
-0.32%+5.83%+9.58%-16.76% 149B
+2.55%+6.55%-10.35%+34.72% 139B
-0.48%+0.84%-55.70%-19.89% 62.81B
-1.69%-1.20%-19.89%-17.59% 48.21B
+0.08%+6.49%+23.87%+39.12% 44.11B
-1.88%+3.25%+40.14%+53.82% 41.42B
-2.27%+16.07%+133.21%+73.20% 36.18B
-1.50%+3.08%-17.64%+59.43% 32.19B
Average -0.65%+5.24%+15.77%+25.77% 84.45B
Weighted average by Cap. -0.31%+5.63%+14.30%+20.00%

Financials

2026 *2027 *
Net sales 6.76B 5.89B 5.57B 5.05B 9.47B 649B 9.51B 66.67B 25.73B 330B 25.39B 24.83B 1,061B 7.43B 6.48B 6.12B 5.55B 10.41B 713B 10.45B 73.27B 28.27B 362B 27.91B 27.29B 1,166B
Net income 1.44B 1.25B 1.18B 1.07B 2.01B 138B 2.02B 14.15B 5.46B 70.01B 5.39B 5.27B 225B 1.9B 1.65B 1.56B 1.42B 2.66B 182B 2.67B 18.71B 7.22B 92.53B 7.12B 6.97B 298B
Net Debt -3.63B -3.17B -2.99B -2.71B -5.09B -348B -5.11B -35.81B -13.82B -177B -13.64B -13.34B -570B -5.19B -4.53B -4.28B -3.88B -7.28B -498B -7.31B -51.23B -19.77B -253B -19.51B -19.08B -815B
Logo Edwards Lifesciences Corporation
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (74%); - hemodynamic monitoring systems (9.1%); - other (16.9%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (25%), Japan (5.8%) and other (10.8%).
Employees
16,000
Date Price Change Volume
26-09-18 US$88.26 +0.01% 4,258,353
26-09-17 US$88.25 -1.15% 3,880,110
26-09-16 US$89.28 +4.13% 5,011,766
26-09-15 US$85.74 +0.26% 3,777,847
26-09-14 US$85.52 +1.36% 2,988,117
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
29
Last Close Price
88.26USD
Average target price
100.96USD
Spread / Average Target
+14.39%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!